BIO Bio-Rad Laboratories, Inc.

NYSE
$370.17

Bio-Rad Laboratories, Inc. (BIO) is expected to report earnings on February 3, 2027, after the market close. The consensus earnings estimate is $2.59 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.8% since its last earnings release on November 4, 2026.

Bio-Rad Laboratories Beat Consensus Estimates
Wednesday, November 4, 2026 · 4:15 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 3
Wednesday · 4:15 PM ET
Earnings Whisper
-
vs $2.59
Rev est $708.17M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $375.92

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.

Sector

Healthcare

Industry

Medical Instruments/Supply

Charts powered in part by Lightweight Charts™ by TradingView.